Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex - PubMed (original) (raw)
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex
Isabelle Herry et al. Eur J Intern Med. 2007 Jan.
Abstract
Angiomyolipomas are very common in patients with tuberous sclerosis complex (TSC) and cause substantial morbidity. Until now, arterial embolization has been the recommended treatment for symptomatic patients. We report the case of a woman with TSC and giant angiolipomas in whom sirolimus induced a dramatic reduction in bilateral renal tumors.
Similar articles
- [The clinical aspects and treatment of renal angiolipomas in patients with tuberous sclerosis].
van Baal JG, Fleury P, Brummelkamp WH. van Baal JG, et al. Ned Tijdschr Geneeskd. 1990 Aug 11;134(32):1556-8. Ned Tijdschr Geneeskd. 1990. PMID: 2392178 Dutch. - Management of renal angiomyolipomas associated with tuberous sclerosis complex.
Harabayashi T, Shinohara N, Katano H, Nonomura K, Shimizu T, Koyanagi T. Harabayashi T, et al. J Urol. 2004 Jan;171(1):102-5. doi: 10.1097/01.ju.0000100100.36354.61. J Urol. 2004. PMID: 14665854 - Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
Krischock L, Beach R, Taylor J. Krischock L, et al. Arch Dis Child. 2010 May;95(5):391-2. doi: 10.1136/adc.2009.159210. Arch Dis Child. 2010. PMID: 20457704 - [Renal cell carcinoma associated with tuberous sclerosis: a case report].
Yasukawa S, Aoshi H, Kyoku I, Uekado Y, Ohkawa T. Yasukawa S, et al. Hinyokika Kiyo. 1989 Dec;35(12):2135-8. Hinyokika Kiyo. 1989. PMID: 2694834 Review. Japanese. - Metastatic breast carcinoma to renal angiomyolipomas in tuberous sclerosis.
Williams TR, Oakes MF. Williams TR, et al. Urology. 2008 Feb;71(2):352.e5-7. doi: 10.1016/j.urology.2007.10.035. Urology. 2008. PMID: 18308125 Review.
Cited by
- Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis.
Sasongko TH, Ismail NF, Nik Abdul Malik NM, Zabidi-Hussin ZA. Sasongko TH, et al. Orphanet J Rare Dis. 2015 Aug 12;10:95. doi: 10.1186/s13023-015-0317-7. Orphanet J Rare Dis. 2015. PMID: 26259610 Free PMC article. Review. - PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.
Krymskaya VP, Goncharova EA. Krymskaya VP, et al. Cell Cycle. 2009 Feb 1;8(3):403-13. doi: 10.4161/cc.8.3.7555. Epub 2009 Feb 6. Cell Cycle. 2009. PMID: 19177005 Free PMC article. Review. - Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH, Ismail NF, Zabidi-Hussin Z. Sasongko TH, et al. Cochrane Database Syst Rev. 2016 Jul 13;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub2. Cochrane Database Syst Rev. 2016. PMID: 27409709 Free PMC article. Updated. Review. - Current management of tuberous sclerosis complex.
Krueger DA, Franz DN. Krueger DA, et al. Paediatr Drugs. 2008;10(5):299-313. doi: 10.2165/00148581-200810050-00004. Paediatr Drugs. 2008. PMID: 18754697 Review.
LinkOut - more resources
Full Text Sources